Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis. [electronic resource]
Producer: 20020513Description: 299-302 p. digitalISSN:- 1528-4042
- Acetates -- therapeutic use
- Amines
- Autoimmune Diseases -- complications
- Baclofen -- administration & dosage
- Benzodiazepines -- therapeutic use
- Botulinum Toxins, Type A -- therapeutic use
- Cannabinoids -- therapeutic use
- Causalgia -- drug therapy
- Clonidine -- analogs & derivatives
- Cyclohexanecarboxylic Acids
- Dantrolene -- therapeutic use
- Dystonia -- drug therapy
- GABA Agonists -- therapeutic use
- Gabapentin
- Humans
- Mechanoreceptors -- physiology
- Multiple Sclerosis -- complications
- Muscle Relaxants, Central -- therapeutic use
- Muscle Spasticity -- drug therapy
- Pain -- drug therapy
- Physical Therapy Modalities
- Receptors, GABA-A -- drug effects
- Receptors, GABA-B -- drug effects
- Relaxation Therapy
- Trigeminal Neuralgia -- drug therapy
- gamma-Aminobutyric Acid
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.